期刊文献+

肝硬化患者凝血功能检测的意义

The Clinical Significance of Detectingcoagulation Function Parameters in Hepatocirrhosis Patients
下载PDF
导出
摘要 目的:探讨肝硬化患者血浆凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原及D-二聚体等凝血功能指标的变化及其意义。方法:确诊的72例不同原因引起的肝硬化患者作为试验组,4 9例健康体检者作为正常对照组。采用美国ACL -Futura全自动凝血仪测定PT、APTT、Fbg及D- 二聚体含量。结果:与正常对照组比较,肝硬化组PT和APTT明显延长(P <0 .0 1) ,Fbg明显减少(P <0 .0 5 ) ,D -二聚体量明显升高(P <0 .0 1) ;且肝硬化患者的Fbg和D- 二聚体含量的异常率明显高于其他两项指标(P <0 .0 5 )。结论:对肝硬化患者进行PT、APTT、Fbg及D -二聚体等凝血功能指标的检测,有助于准确地评价肝硬化患者肝脏损害的严重程度及其预后的判定,并对预防肝硬化患者是否有出血倾向等并发症的发生,具有重要的医学意义。 Objective To investigate the variation and clinical significance of several coagulation function parameters,fuch as prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(Fbg)and D-dimer in hepatocirrhosis patients. Methods There are 72 hepatocirrhosis patients,who have been diagnosed,as test group,while other 49 healthy people as control group.Through automatic coagulometer of Amehcan ACL-Futura Corporation,we measure the parameters mentioned above.Results In comparison with control group,the Value of PT、APTT and D-dimer are significantly higher (P<0.01)in patient group respectively,But the Value of Fbg of patient group are significantly lower than control group(P<0.05);the abnormal ratio of the value of Fbg and D-dimer are Significantly higher(P<0.05)than the other two parameters.Conclusion The detections of these coagulation function parameters,such as PT,APTT,Fbg and D-dimer,have important clinical significance.And they are useful for evaluating the severity of the liver and estimatingprogonosis and preventing the occurrence of syndrome in hepatocirrhosis pahents.
机构地区 荆州中心医院
出处 《实用医技杂志》 2005年第03B期699-700,共2页 Journal of Practical Medical Techniques
关键词 肝硬化 凝血功能 异常率 hepatocirrhosis coagulation function abnormal ratio
  • 相关文献

参考文献5

二级参考文献40

  • 1马育华,毕春霞,闫志勇,郭建金.肾病综合征病人血浆D-二聚体的检测及临床意义[J].齐鲁医学杂志,1998,13(2):31-31. 被引量:2
  • 2杨微波,陈镇英,韦嘉,段勇,王玉明.影响乙肝后肝硬化预后因素的逐步回归分析[J].昆明医学院学报,1995,16(3):71-72. 被引量:1
  • 3李爱增 贺石林.血栓病学[M].北京:科技出版社,1998.79.
  • 4Sadler IE.Thrombomodulin structure and function[J]. Thromb Haemost ,1997,78:394
  • 5Aso Y,Innkai T,Takemura T ,et al. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients :possible application as a marker for vascular endothelial injury[J]. Metabolism, 1998,47:362
  • 6Ridker PM, Hennekens CH,Cerskus A, et al. Plasma concentration of D-dimer and the risk of future myocardial infarction among apparently health men[J]. Circulation, 1997,96(3):1053
  • 7Michiels JJ,Pattynama PM. Exclusion and diagnosis of pulmonary embolism by a rapid ELISA D-dimer test and noninvasive imaging techniques within the context of a clinical model[J]. Clin Appl Thromb Hemost, 2000,6(1),49
  • 8Nakasaki T,Wada H,Mori Y, et al. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia[J]. Am J Hematol ,2000,64(3):145
  • 9Sumida Y,Wada H,Fujii M, et al. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus[J]. Blood Coag Fibr ,1997,8:305
  • 10Boffa MC ,Karmochkine M. Thrombomodulin on overview and potential implications in vascular disorders [J] .Lupus,1998,7 (Suppl 2) :121

共引文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部